Company intelligence / Profile preview

Crofoot Research Center

Ownership: Private
Development stage: Commercial

Overview

Crofoot Research Center is a leading independent clinical trial site specializing in infectious diseases—primarily HIV. It has participated in over 130 clinical trials since the 1980s, including pivotal studies of antiretrovirals and vaccines. Recent work includes Phase 3 studies of long acting agents like lenacapavir for both treatment and prevention of HIV. The center has contributed to landmark advances such as early AZT testing, digital patient consent innovation, and outreach to underserved communities.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeBiologic (including monoclonal antibody)
Industry: Contract Research Organization

Partnerships

Gilead Sciences (multiple sponsored trials)Janssen Vaccines & Prevention BV/J&J/Janssen Pharmaceuticals [Mosaico AIDS vaccine trial]

Beyond the preview

Go deeper on Crofoot Research Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crofoot Research Center.

Explore the full profile